// Submental fat reduction

Kybella

Kybella (deoxycholic acid)

An FDA-approved injectable that destroys fat cells under the chin (submental fat). Permanently reduces the "double chin" silhouette in candidates who fit the indication.

What it is

Kybella is synthetic deoxycholic acid — the same molecule the body uses to break down dietary fat. Injected into the submental fat compartment, it disrupts the fat cell membranes; the contents are cleared over weeks. The destroyed fat cells do not return.

How we approach it

Kybella suits a specific patient: modest to moderate submental fullness, reasonable skin elasticity, and willingness to commit to a series.

The first visit includes a candid evaluation: is the chin profile a fat problem or a skin problem? Patients with significant laxity often look worse, not better, after fat loss alone. For those patients, we recommend assessing skin tightening (radiofrequency or ultrasound) first or in combination.

When Kybella is the right call, treatment is mapped — a grid of injections placed at safe-zone intervals — and dose is calibrated to the area and the session number.

What to expect

Swelling is the defining post-treatment experience. The neck and chin will be noticeably swollen for two to seven days; firmness and soreness may persist a week or two. Most patients plan around this. A “look thicker before thinner” phase is normal.

Most candidates require two to three sessions spaced four to six weeks apart. Final result is judged at one to three months after the last session.

Candidacy

Good candidates have submental fullness as the primary complaint, with adequate skin tone to retract after fat loss. Poor candidates have significant skin laxity, active infection in the treatment area, or are pregnant or nursing. If Kybella is not the right call, the clinician will recommend the alternative — typically tightening, sometimes nothing at all.

Indicated for

  • Patients with modest to moderate submental fullness
  • Patients with reasonable skin elasticity who will retract well after fat loss
  • Patients who prefer a series of small visits over a surgical option

Not a candidate if

  • Patients with significant skin laxity — fat loss may worsen the appearance; consider tightening first
  • Patients with active infection or open skin in the treatment area
  • Pregnant or nursing patients
  • Patients who cannot tolerate visible swelling for several days after each session

Before your visit

  • Swelling is real and visible — sometimes substantial — for the first three to seven days
  • Most patients require two to three sessions spaced 4–6 weeks apart
  • Marginal mandibular nerve injury (temporary smile asymmetry) is a rare but recognized risk; the injector maps the safe zone before placement

Begin with the consultation.

Every plan is drawn before it is performed. The team trains under Dr. Brown.